Haoxi Health Technology Limited

Haoxi Health Technology Limited

HAO
Haoxi Health Technology LimitedUS flagNASDAQ Capital Market
1.09
USD
-0.14
- -
63,893.00Market Cap
Haoxi Health Technology Limited
HAO
(NASDAQ Capital Market)

Recent

price

1.09

P/E

ratio

- -

div

yld

- -

ROIC.AI

2021
2022
2023
2024
2025
FRC
10.9
14.63
25.56
39.64
- -
Revenue per Share
0.26
0.22
0.88
1.06
- -
Basic EPS, GAAP
2.24
-0.62
-0.83
-0.66
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
-1.51
-1.39
-0.51
0.59
- -
Book Value per Share
0.06
-1.33
1.42
9.21
- -
Tangible Book Value per Share
1
1
1
1
2
Basic Weighted Avg Shares
13
16
28
49
- -
Sales/Revenue/Turnover
2.57
1.66
4.24
3.54
- -
Operating Margin (%)
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
1
1
- -
Net Income, GAAP
6.52
5.78
18.54
25.56
- -
Effective Tax Rate (%)
2.37
1.51
3.44
2.66
- -
Profit Margin (%)
- -
-2
1
12
- -
Working Capital
- -
- -
- -
- -
- -
LT Debt
- -
-1
2
11
- -
Total Equity
- -
- -
108.48
15.72
- -
Return on Invested Capital (%)
- -
-20.5
-264.64
119.53
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
49
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1.06
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Business
Haoxi Health Technology Limited, operating through its subsidiaries, delivers comprehensive online advertising solutions across China. The company specializes in developing and executing online marketing strategies, with a particular emphasis on short video formats, to assist advertisers through its broad network of media collaborators. These tailored services encompass the entire ad lifecycle, from strategic planning and creative development to placement and continuous optimization of digital advertisements, enabling clients to attract, convert, and retain consumers on prominent digital platforms such as Toutiao, Douyin, WeChat, and Sina Weibo. Primarily serving the healthcare and rapidly expanding medical aesthetics industries, the firm enhances its offerings with proprietary data analytics software and recent integrations of generative AI through a strategic partnership. Established in 2018, Haoxi Health Technology is headquartered in Beijing, China, and has recently introduced specialized livestreaming agency services.

Company News

APIChat
  • Haoxi Health Technology Limited Announces 1-For-128 Reverse Share Split

  • Univest Securities, LLC Announces Closing of $6.5 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)

  • Univest Securities, LLC Announces Closing of $6.5 Million Registered Direct Offering for its Client Haoxi Health Technology Ltd (NASDAQ: HAO)

  • Haoxi Health Technology Ltd Announces $6.5 Million Registered Direct Offering

  • Haoxi Health Technology (NASDAQ:HAO) Shares Up 0.1% – Still a Buy?

  • Haoxi Health Technology (NASDAQ:HAO) Trading Down 0.9% – Time to Sell?

  • Haoxi Health Technology (NASDAQ:HAO) vs. Direct Digital (NASDAQ:DRCT) Head to Head Contrast

  • Haoxi Health Technology Limited Launches Customized Livestreaming Agency Strategy

  • Haoxi Health Technology Limited Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

  • Haoxi Health Technology Limited Announces 1-for-25 Reverse Share Split

  • Haoxi Health Technology Limited Awarded a RMB30 Milllion Framework Contract to Provide Digital Advertising Services for Tengyuan Media Advertising Co., Ltd.

  • Haoxi Health Technology Limited Reports Financial Results for Fiscal Year Ended June 30, 2024

  • Haoxi Health Technology Limited Announces Preliminary Unaudited FY24 Financial Results with projected 72% Revenue Growth

  • Haoxi Health Technology Limited and Global Mofy AI Ltd Announce Strategic Partnership to Innovate AI Marketing Solutions

  • Haoxi Health Technology Limited Announces the Closing of a $12 Million Underwritten Follow-on Public Offering

  • Haoxi Health Technology Limited Announces Pricing of a $12 Million Underwritten Follow-on Public Offering

  • Haoxi Health Technology Limited Facilitates International Humanitarian Aid Efforts Amid Global Challenges

  • Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended December 31, 2023

  • Haoxi Health Technology Limited Enters into Rebate Agreement with Clients on Advertising Placement Campaign

  • Haoxi Health Technology Limited Enters into Advertising Placement Service Framework Contract